25,092
Total Claims
$1.4M
Drug Cost
1,723
Beneficiaries
$804
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-43%
Cost per patient vs peers
$804 vs $1,411 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 22,832 claims · $279K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sacubitril/Valsartan | 458 | $327K |
| Apixaban | 432 | $270K |
| Rivaroxaban | 325 | $215K |
| Ticagrelor | 252 | $128K |
| Dapagliflozin Propanediol | 129 | $87K |
| Empagliflozin | 73 | $51K |
| Metoprolol Succinate | 2,068 | $30K |
| Losartan Potassium | 1,918 | $21K |
| Atorvastatin Calcium | 2,373 | $21K |
| Amlodipine Besylate | 2,253 | $10K |
| Irbesartan | 442 | $9,807 |
| Hydrochlorothiazide | 1,503 | $8,709 |
| Clopidogrel Bisulfate | 950 | $8,521 |
| Simvastatin | 1,485 | $8,391 |
| Enalapril Maleate | 288 | $8,004 |
Prescribing Profile
82
Unique Drugs
$949K
Patient Profile
75
Avg Age
56%
Female
2.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data